Doripenem in the Treatment of Patients with Nosocomial Pneumonia: A Meta-Analysis

Doripenem in the Treatment of Patients with Nosocomial Pneumonia: A Meta-Analysis

Introduction: Clinically, doripenem therapy for nosocomial pneumonia remains a serious concern. The purpose of this meta-analysis was to explore the efficacy and the safety of doripenem therapy for nosocomial pneumonia in comparison with other antimicrobial agents. Methods: Studies were eligible for...

Full description

Bibliographic Details
Main Authors:	Chienhsiu Huang, Ihung Chen, Yalun Yang
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Journal of Clinical Medicine
Subjects:	doripenem hospital-acquired pneumonia ventilator-associated pneumonia <i>Pseudomonas aeruginosa</i>
Online Access:	https://www.mdpi.com/2077-0383/11/14/4014

Similar Items

CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
by: I. I. Shteynberg, et al.
Published: (2015-03-01)

Actividad in vitro de doripenem comparado con meropenem frente a aislamientos de Pseudomonas aeruginosa en un centro asistencial de tercer nivel de Bogotá (Colombia) Activity of Doripenem compared to Meropenem against Pseudomonas aeruginosa isolates at Tertiary Care Teaching Hospital in Bogotá (Colombia)
by: Adriana Jiménez, et al.
Published: (2012-12-01)

Nozokomiyal Pseudomonas Aerugınosa İzolatlarında Doripenem Duyarlılık Oranlarının E-Test Yöntemiyle Araştırılması
by: Abdullah Bektaş, et al.
Published: (2011-09-01)

Nosocomial pneumonia in critically ill patients
by: Dandagi Girish
Published: (2010-01-01)

MODERN ANTIBACTERIAL THERAPY IN HOSPITAL-ACQUIRED PNEUMONIA
by: V. B. Beloborodov, et al.
Published: (2017-11-01)

Clinical, epidemiological and evolution of severe nosocomial pneumonia in intensive care unit
by: Abel Arroyo- Sanchez, et al.
Published: (2016-03-01)

Microbiological Profile of Bronchoalveolar Lavage in Patients with Nosocomial Pneumonia in Intensive Care Unit
by: Kalyani Sri Koneru, et al.
Published: (2018-07-01)

Características clínicas, epidemiológicas y evolución de la neumonía nosocomial severa en la unidad de cuidados intensivos
by: Edwin Albino H., et al.
Published: (2016-01-01)

Ceftolozane/tazobactam probability of target attainment and outcomes in participants with augmented renal clearance from the randomized phase 3 ASPECT-NP trial
by: Andrew F. Shorr, et al.
Published: (2021-10-01)

Comparison of in Vitro Activity of Doripenem versus Old Carbapenems against Pseudomonas Aeruginosa Clinical Isolates from both CF and Burn Patients
by: Reza Bigverdi, et al.
Published: (2013-02-01)

A case of community acquired pneumonia with Pseudomonas aeruginosa
by: K Jayatilleka, et al.
Published: (2012-08-01)

Management of mechanical ventilation in patients with hospital-acquired pneumonia: A retrospective, observational study
by: Radovan Uvizl, et al.
Published: (2018-06-01)

How to diagnose, treat and prevent from hospital-acquired and ventilator-associated pneumonia?
by: Rafał Babiak, et al.
Published: (2023-06-01)

Assessing the Impact of Gender and COPD on the Incidence and Mortality of Hospital-Acquired Pneumonia. A Retrospective Cohort Study Using the Spanish National Discharge Database (2016–2019)
by: Javier de-Miguel-Diez, et al.
Published: (2021-11-01)

The COVID-19 Pandemic and the Incidence of the Non-COVID-19 Pneumonia in Adults
by: Chienhsiu Huang
Published: (2021-11-01)

Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia
by: Yun Jung Jung, et al.
Published: (2022-01-01)

Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and Management
by: Elena Xu, et al.
Published: (2021-03-01)

Pattern of community and hospital acquired pneumonia in Egyptian military hospitals
by: Magdy Mohammad Khalil, et al.
Published: (2013-01-01)

Prognosis of hospital‐acquired pneumonia/ventilator‐associated pneumonia with Stenotrophomonas maltophilia versus Klebsiella pneumoniae in intensive care unit: A retrospective cohort study
by: Shuping Chen, et al.
Published: (2022-10-01)

Frequency of Ventilator-associated Pneumonia With 3-day Versus 7-day Ventilator Circuit Changes
by: Ting-Chang Hsieh, et al.
Published: (2010-02-01)

Differences in microbial etiology between hospital-acquired pneumonia and ventilator-associated pneumonia: a single-center retrospective study in Guang Zhou
by: Feng DY, et al.
Published: (2019-04-01)

Incidence of ventilator-associated pneumonia: Egyptian study
by: Reham M. Elkolaly, et al.
Published: (2019-05-01)

The importance of Clinical Research
by: Frank Lizaraso Caparó, et al.
Published: (2016-01-01)

Incidence, Outcomes and Sex-Related Disparities in Pneumonia: A Matched-Pair Analysis with Data from Spanish Hospitals (2016–2019)
by: Jose M. de Miguel-Yanes, et al.
Published: (2021-09-01)

Microbiological analysis of nosocomial pneumonia at Tanta University Chest Hospital
by: Amira Abdelgalil Elkholy, et al.
Published: (2023-08-01)

Ventilator-associated pneumonia: Its incidence, the risk factor and drug resistance pattern in a tertiary care hospital
by: Sourabh Mitra, et al.
Published: (2015-01-01)

Characterisation of aerobic bacteria isolated from endotracheal aspirate in adult patients suspected ventilator associated pneumonia in a tertiary care center in Mangalore
by: Ramakrishna Pai Jakribettu, et al.
Published: (2012-01-01)

Pseudomonas aeruginosa ventilator-associated pneumonia management
by: Ramírez-Estrada S, et al.
Published: (2016-01-01)

Ceftolozane/Tazobactam for Resistant Drugs <i>Pseudomonas aeruginosa</i> Respiratory Infections: A Systematic Literature Review of the Real-World Evidence
by: Luca Gregorio Giaccari, et al.
Published: (2021-05-01)

Bacterial Colonisation and Antibiotic Sensitivity Profile of Endotracheal Tubes in Mechanically Ventilated Patients
by: Hemanth Natham, et al.
Published: (2019-01-01)

The rapid in vivo evolution of Pseudomonas aeruginosa in ventilator-associated pneumonia patients leads to attenuated virulence
by: Wang, Ke, et al.
Published: (2019)

The rapid in vivo evolution of Pseudomonas aeruginosa in ventilator-associated pneumonia patients leads to attenuated virulence
by: Ke Wang, et al.
Published: (2017-01-01)

Cavitary lesions emerged rapidly in Pseudomonas aeruginosa pneumonia
by: Naoki Kawakami, et al.
Published: (2020-03-01)

Molecular characterization of methicillin-resistant Staphylococcus aureus clinical strains from the endotracheal tubes of patients with nosocomial pneumonia
by: Roberto Cabrera, et al.
Published: (2020-02-01)

Lower neutrophil-to-lymphocyte ratio predicts high risk of multidrug-resistant Pseudomonas aeruginosa infection in patients with hospital-acquired pneumonia
by: Zhou YQ, et al.
Published: (2018-10-01)

Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018
by: Michael A. Pfaller, et al.
Published: (2021-11-01)

Infectious Pneumonia and Lower Airway Microorganisms in Patients with Rheumatoid Arthritis
by: Shuhei Ideguchi, et al.
Published: (2021-08-01)

Association between combination antibiotic therapy as opposed as monotherapy and outcomes of ICU patients with Pseudomonas aeruginosa ventilator-associated pneumonia: an ancillary study of the iDIAPASON trial
by: Arnaud Foucrier, et al.
Published: (2023-05-01)

Implementation of the TaperGuard™ endotracheal tube in an unselected surgical population to reduce postoperative pneumonia
by: Ross P. Martini, et al.
Published: (2020-08-01)

Lower respiratory tract infections treatment recommendations: An overview
by: Elli Malakounidou, et al.
Published: (2023-07-01)